With a new endorsement from the FDA, Novo Nordisk’s Wegovy has picked up its third indication and become the second drug ...

The FOB5 Sets a New Benchmark for Pharma and Biotech Labs | Discover how Fedegari’s FOB5 is redefining sterilization with ...

Every year, we celebrate women making a powerful impact across biopharma and medtech, and it’s time once again to make your ...

Tonix Pharmaceuticals was founded in 2010 to develop and bring to market a drug for fibromyalgia. | Tonix Pharmaceuticals was ...

After taking a $50 million hit in a patent lawsuit targeting its leukemia med Blincyto last year, Amgen has convinced a ...

FluMist has been approved since 2003, but—until last year—only for administration by a healthcare practitioner. The new nod ...

With £60 million ($81.4 million) raised through recent share sales, the CDMO OXB has its eyes on a U.S. expansion. | The CDMO ...

The China-based phase 3 trial of telitacicept in primary Sjögren's syndrome (pSS) met its primary endpoint, which focused on ...

With its domination of the indication- and brand-specific analyses, it should come as no surprise that AstraZeneca led the ...

Texas Attorney General Ken Paxton and Health Choice Alliance are accusing Eli Lilly of “incentivizing” providers in the state ...

San Diego CDMO TriLink BioTechnologies is reducing its headcount while its parent company, Maravai LifeSciences, moves ...

Merck has begun the 8% reduction of its workforce—an initiative that the company revealed two weeks ago—with the dismissal of ...